Controversies in diagnosis and treatment of hepatitis C. Which patients benefit most from therapy?
Hepatitis C virus has recently been identified as an important cause of morbidity and mortality worldwide. Acute hepatitis C infection is clinically indistinguishable from other types of viral hepatitis but is much more likely to become chronic. Chronic hepatitis C is a significant cause of cirrhosis and hepatocellular carcinoma. While modes of transmission, diagnosis, and treatment are currently controversial, Dr Brady discusses some approaches for dealing with this emerging problem.
Brady
W M
WM
Section of General Internal Medicine, Temple University School of Medicine, Philadelphia, USA.
D000998:Antiviral Agents / Q000627:therapeutic use; D006526:Hepatitis C / Q000175:diagnosis* / Q000628:therapy* / Q000635:transmission; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use; D018579:Patient Selection
D000998:Antiviral Agents; D016898:Interferon-alpha